[
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=0f55029c6fb7eea8950b7330013208a6d479c66b215f9282a78663d699ae1e7c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738168380,
      "headline": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
      "id": 132522124,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=0f55029c6fb7eea8950b7330013208a6d479c66b215f9282a78663d699ae1e7c"
    }
  },
  {
    "ts": null,
    "headline": "Earnings Preview: Thermo Fisher Is Facing Way Too Many Headwinds",
    "summary": "Thermo Fisher is a Life Sciences giant with over $42 billion in yearly revenues and 120 thousand employees. Find out why I give TMO a contrarian sell rating.",
    "url": "https://finnhub.io/api/news?id=f7718a85b85cc73e6e172ba82c50555c8b7b2b5eb074beac56e53fe46a064153",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738146900,
      "headline": "Earnings Preview: Thermo Fisher Is Facing Way Too Many Headwinds",
      "id": 132493221,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1583180369/image_1583180369.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Thermo Fisher is a Life Sciences giant with over $42 billion in yearly revenues and 120 thousand employees. Find out why I give TMO a contrarian sell rating.",
      "url": "https://finnhub.io/api/news?id=f7718a85b85cc73e6e172ba82c50555c8b7b2b5eb074beac56e53fe46a064153"
    }
  },
  {
    "ts": null,
    "headline": "Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO",
    "summary": "WATERTOWN - Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the Board of Directors has appointed Adam Sayer as President and...",
    "url": "https://finnhub.io/api/news?id=a733cff4b0140d8ce4b48a294de339f67e801b0803e91b4ba095e5e1d321f7b6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738136485,
      "headline": "Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO",
      "id": 132492077,
      "image": "",
      "related": "TMO",
      "source": "Finnhub",
      "summary": "WATERTOWN - Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the Board of Directors has appointed Adam Sayer as President and...",
      "url": "https://finnhub.io/api/news?id=a733cff4b0140d8ce4b48a294de339f67e801b0803e91b4ba095e5e1d321f7b6"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Appreciation Fund Q4 2024 Commentary",
    "summary": "US equities delivered positive gains in the fourth quarter and finished the 12-month period up 25% for the second year in a row. Read more here.",
    "url": "https://finnhub.io/api/news?id=8dc013d99ef520c7f5903fb80adbd52e4a90b613357ecd622efcf00be060f355",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738131360,
      "headline": "ClearBridge Appreciation Fund Q4 2024 Commentary",
      "id": 132491696,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1395549655/image_1395549655.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "US equities delivered positive gains in the fourth quarter and finished the 12-month period up 25% for the second year in a row. Read more here.",
      "url": "https://finnhub.io/api/news?id=8dc013d99ef520c7f5903fb80adbd52e4a90b613357ecd622efcf00be060f355"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Large Cap Growth ESG Strategy Q4 2024 Commentary",
    "summary": "The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=00c8dc44289fdc166f4a31d57b1af9002d4f44ce3b2eedcf50456b9cc61f0b6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738122900,
      "headline": "ClearBridge Large Cap Growth ESG Strategy Q4 2024 Commentary",
      "id": 132491008,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1567022490/image_1567022490.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=00c8dc44289fdc166f4a31d57b1af9002d4f44ce3b2eedcf50456b9cc61f0b6d"
    }
  }
]